Severe colitis caused by biologics: What an endoscopist needs to know

Minerva Gastroenterologica e Dietologica

Volumn 60, Issue 4, 2014, Pages 287-290

  Ratuapli, S K ^a   Depetris, G ^a   Shepard, B ^b   Nguyen, C C ^a  

^a MAYO CLINIC   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IPILIMUMAB; PREDNISOLONE; STEROID; ANTINEOPLASTIC AGENT; GLUCOCORTICOID; MONOCLONAL ANTIBODY;

ADULT; ASCENDING COLON; CASE REPORT; COLITIS; COLON BIOPSY; COLON ULCER; COLONOSCOPY; DESCENDING COLON; DRUG INDUCED COLITIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EDEMA; ERYTHEMA; FAINTNESS; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTESTINE PERFORATION; LETTER; MALE; MELANOMA; MIDDLE AGED; RECTUM HEMORRHAGE; RECTUM ULCER; SIGMOID; TRANSVERSE COLON; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; GASTROENTEROLOGY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLITIS, ULCERATIVE; COLONOSCOPY; GASTROENTEROLOGY; GLUCOCORTICOIDS; HUMANS; MALE; MELANOMA; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84923796650     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Weber J. Review anti-CTLA-4 antibody ipilimumab: case.studies of clinical response and immune-related adverse events. Oncologist 2007; 12: 864-72
2. Lord JD, Hackman RC, Moklebust A, Thompson J.A., Higano CS, Chielens D et al. Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells. Dig Dis Sci 2010; 55:1396-405.
3. Berman D, Parker SM, Siegel J, Chasalow S.D., Weber J., Galbraith S et al. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun 2010; 10-11.
4. De Petris G, Caldero SG, Chen L, Xiao S.Y., Dhungel BM, Spizcka AJ et al. Histopathological changes in the gastrointestinal tract due to drugs an update for the surgical pathologist (Part I of II). Int J Surg Pathol 2014; 22: 202-11
5. Gentile NM, D'Souza A, Fujii IX, Wu T.T., Murray JA Association between ipilimumab and celiac disease. Mayo Clin Proc 2013; 88:414-7.